A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis
Clinical trial NCT04772079 · RECRUITING
Trial details
- NCT number
- NCT04772079
- Sponsor
- Bristol-Myers Squibb
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-23
- Primary completion
- 2029-01-01
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.